“Catheter-Pens” - an Alternative to Insulin Pump Treatment?^*)

Abstract

Two types of insulin pens MADI and MD, were connected to subcutaneous catheters. These "catheter-pens" were used like hand-driven insulin pumps. Results after 1 year of treatment in 30 type 1 diabetics (HCP-negative; age at onset of diabetes 16.5 +/- 1.7 years; duration of diabetes 18.5 +/- 1.6 years, on multiple insulin injections before catheter-pen application): 1. better quality of life (reduction of frequency of needle pricks, more flexibility, inconspicuous application of insulin in public); 2. daily insulin--increased number of "injections" (4.2 +/- 0.1 vs 5.8 +/- 0.1, p less than 0.01), reduction of units per kg BW (0.70 +/- 0.02 vs 0.60 +/- 0.01, p less than 0.01), reduction of intermediate-acting insulin (14.1 +/- 1.3 vs 9.2 +/- 1.2 U/d, p less than 0.05); 3. no change of HbA1 (10.8 +/- 0.8 vs 10.2 +/- 0.2%, normal range 7.7 to 8.4%), mean blood glucose (MBG) in stress situation (8.4 +/- 0.4 vs 7.7 +/- 0.3 mmol/l), serum cholesterol and body weight, both within normal range; 4. improvement (p less than 0.05) of serum triglycerides, serum HDL-cholesterol, ratio of apolipoprotein A1/B; 5. rare skin reactions at the needle site. Conclusion. Catheter-pens offer a very convenient alternative for insulin administration in intensified conventional insulin treatment with multiple injections in type 1 diabetics.

Benefits of Implementation of Insulin Pump in People with Type 1 Diabetes: 10 Case Reports

“…Anna's description of her medical care from 1983 to 1991 is vague. In 1992, she was referred to a diabetes center and received MADI (manual insulin dispenser) [22]. In 1993, she obtained her first glucometer, which Anna describes as a milestone in her life as a person with T1D.…”

Intensive Management of Type 1 Diabetes in Adults: One Centre Experience 1970–2022

“…This chapter is focused on selected clinical trials and routine management of people with type 1 diabetes (PWD1) carried out since the year 1970 at the Teaching Hospital and Palacký University Olomouc [55,56], mostly in cooperation with experts from diabetes centres in the Czech and Slovak Republics [57], Institute of Diabetes G. Katsch Karlsburg [58][59][60][61][62][63][64][65][66][67][68][69][70][71][72][73][74][75][76], Heinrich Heine Universität Düsseldorf [77], Royal Infirmary Edinburgh [62] and St. Thomas Hospital London [62,78].…”

Ομαδική Ψυχοεκπαιδευτική Παρέμβαση Σε Ασθενείς Με Διαβήτη Τύπου ΙΙ Με Στόχο Τη Βελτίωση Της Ποιότητας Ζωής Τους

“…Γενικότερα, οι κλίμακες D.T.S.Q. αποδείχθηκαν ιδιαιτέρως χρήσιμες στις κλινικές δοκιμές που αξιολογούν νέες τεχνολογίες στη θεραπεία όπως είναι οι υποδόριες εγχύσεις ινσουλίνης CSII (Bradley, Meadows & Sowden, 1992, 1992a˙ Jennings et al, 1991 και άλλες συσκευές (Menzel, Chlup, Jutzi & Hildman, 1990), στην εισαγωγή ινσουλίνης σε ασθενείς με δισκιοθεραπευόμενο διαβήτη (Bradley & Lewis, 1990˙ Jennings et al, 1991, καθώς και στη μέτρηση των αποτελεσμάτων εκπαιδευτικών προγραμμάτων για το ΣΔ (Lewis et al, 1988 , με έρπη γεννητικών οργάνων (Taback & Bradley, 2000), με Η.Ι.V. (Woodcock & Bradley, 2001), καθώς και με διαβητική αμφιβληστροειδοπάθεια (Speight et al, 2003).…”